To mvestlgate whether 20-HETE-induced relaxations were related to release of prostacychn, we measured the release of 6-keto PGF,,, the stable metabohte of prostacyclm, from bovine coronary arteries 20-HETE
B Campbell
Abstract-Neutrophlls respond to lschemlc injury by infiltrating the myocardmm via the vascular wall During this process, neutrophlls are activated and release mflammatory mediators Some of these mediators are metabohtes of arachldomc acid We have reported that neutrophlls metabolize arachldomc acid to 20-HETE, a cytochrome PbsO metabohte We investigated the effects of 20-HETE on coronary vascular tone by exammmg 20-HETE-induced changes m lsometrlc tension m bovine coronary artery rings precontracted with the thromboxane-rmmetlc, U46619 20-HETE relaxed precontracted coronary rings m a concentration-dependent manner (EC,, of 3 X lo-' mol/L) Pretreatment with mdomethacm, a cyclooxygenase mhlbltor, shifted the concentration-response curve to the nght (EC,, of 1 X 10e6 mol/L), maximal relaxations were not affected This suggested that 20-HETE-induced relaxations were, m part, dependent on the cyclooxygenase pathway Relaxations to 20-HETE were not significantly changed m endothehum-denuded rings To determine whether metabolism of 20-HETE to a vasoactlve compound nught explain the relaxations caused by 20-HETE, rings of coronary artery were incubated with [3H] 20-HETE The mcubatlon buffer was extracted and the [3H] products resolved on reverse-phase HPLC Both denuded and intact arteries failed to metabolize [3H] 20-HETE To mvestlgate whether 20-HETE-induced relaxations were related to release of prostacychn, we measured the release of 6-keto PGF,,, the stable metabohte of prostacyclm, from bovine coronary arteries 20-HETE
(1 X lo-" mol/L) stimulated an increase m 6-keto PGF,, m intact vessels (908 -+ 138 pg/mL versus 1402 -' 157 pg/mL, basal versus stimulated)
Thus, 20-HETE-induced relaxations are due, m part, to the stlmulatlon of the release of the dilatory prostanold, prostacyclm (H~~evtension.
1998;31[part 2]:237-241.)
Key Words: neutrophlls n cytochrome P450 n coronary artery n prostacychn n endothehum n cyclooxygenase T he interaction between vascular endothehal cells and neutrophlls 1s lmphcated as a major component of the mechanism of myocardlal nchemla reperfuslon injury ' During reperfuslon of a formerly lschemlc myocardlal region, neutrophlls localize to damaged tlnue and adhere to endothehal ceils ' After they adhere to the endothehum and are activated, neutrophlls release several agents capable of causing cellular damage beyond that incurred durmg the period of lschemla ' ' Because neutrophlls are presumed to be responsible for most damage that occurs after the onset of reperfuslon, reperfusmg damaged tissue with blood devoid of leukocytes reduces the amount of tissue damage '-' However, because neutrophlls also have recuperative effects, completely lrradlcatmg neutrophlls may be a less effective therapy than targeting only the potentially destructive compounds they release ' Among the compounds released by activated neutrophlls dunng reperfuslon are arachldomc acid and its metabohtes ' Increased phosphohpase activity durmg lschemla and ATP depletion liberates arachldomc acid from phosphohpld stores, subsequently making arachldomc acid metabohsm more efflclent dunng the period after reperfiislon '-' Neutrophlls metabolize arachrdomc acid usmg all three major enzymes mvolved m its metabolism cyclooxygenase, cytochrome P4?,,, and hpoxygenase ' Arachldomc acid metabohtes from all three enzymatic pathways are known to be vasoactlve Leukotnenes, denved from the hpoxygenase pathway, act as either vasoconstnctors or ;asodllators, depending on the vascular tissue being exammed "' Prostaglandm I2 (PGIJ, or prostacychn, 1s a product of the cyclooxygenase pathway m coronary vascular endothehum and 1s a known coronary vasodllator " '* The vascular reactivity of prostacychn provides therapeutic effects against coronary artery thrombosis characterlstlc of myocardlal lschemla and the "no-reflow" phenomenon M' A variety of cytochrome P450 metabohtes affect vascular tone, including the w-hydroxylase product 20-HETE, derived from arachldomc acid, 1s released from activated neutrophlls" and contributes to vascular tone m a number of organ systems "-" Because 20-HETE can be metabolized m much the same way as arachldomc acid,*" a number of the effects of 20-HETE are attributed to metabolism by the cyclooxygenase pathway l7 20-HETE constricts rabbit aorta and mesentenc, cortical, and renal arteries only 111 the presence of cyclooxygenase actlvlty and the vascular endothehum, suggesting that cyclooxygenase metabolism of found that 20-HETE dose-dependently increased the production of 6-keto PGF,,, and thus, this may explain part of the vasodllatory effects of 20-HETE
Methods

Vascular Reactivity
Bovine hearts (2 to 4 kg) were obtained from the local slaughterhouse The epicardial left antenor descending coronary artery was dlssected, cleaned of adhering fat and connectwe tissue, and placed m a Krebs bicarbonate solution containing the followmg (m mmol/L) NaCl (119). KC1 (5), NaHCO, (24), KH,PO, (1 2), MgSO, (1 2), glucose (ll), EDTA (0 02), and C&l, (3 2) The vessels were cut mm rings and care was taken to avoid damagmg the endothelmm In some vessels, the endothehum was dehberately removed by gently rubbmg the lumen with forceps The rmgs were suspended on a pair ofstamless steel hooks m a 15-mL water-jacketed organ chamber One hook was anchored to a steel rod and the other was attached to a force transducer (model FT-03C, Grass Instruments) Tension was recorded on a Grass model 7D polygraph (Grass Instruments) The organ chamber was filled with Krebs bicarbonate solution that was bubbled with 95% 02/5% CO2 and mamtamed at 37'C The vessels were challenged with repeated exposures to 20 mmol/L KC1 and progresswe mcreases m basal tenslon to determme the optimal restmg tenslon This tension was found to be 2 g for vessels of 2-mm diameter The eflluent was collected m 0 2-mL fractions, mixed with scmtlliatlon flmd, and the radloactlvlty was measured by hqmd scmtlllatlon spectrometry to obtain a profile of radloactlve metabohtes
Release of Prostaglandin Iz by Bovine Coronary Arteries
Vessels were dlssected from bovine hearts as described previously and cut mto rmgs (2-to 4-mm diameter) 6-Keto PGF,, was measured m smgle rmgs m the absence of tension Rmgs were placed m 1 mL of HEPES buffer and maintained at 37'C for 10 minutes m the presence of lo-* mol/L of U46619 to mlrnlc the organ chamber condltlons 20-HETE (lo-' and IO-" mol/L) was then added and the mcubatlon continued for 15 mmutes At the end of the mcubatlon period, the media was decanted and exammed for production of PGI, by radlolmmunoassay of Its stable metabohte 6-keto PGF,, as previously described 24 20-HETE m concentrations of 1 X 10m6 and 1 X 10m5 mol/L did not cross-react with the 6-keto PGF,, antibody or alter the displacement ['HI 6-keto PGF,, by 6-keto PGF,, (data not shown)
Statistics
Statlstlcal analysis was performed by ANOVA to determine slgmficant differences among groups, followed by Dunnet's modlficatmn of the t test to determine differences between groups A value of P < 05 was considered statlstlcally sign&cant
Materials
Both 6-keto PGF,, and prostacychn were purchased from Cayman Chemicals Company Methachohne, bradykmm, A23187, and most of the other chemicals were purchased from Sigma Chemical Company , were purchased from Du Pont NEN Life Sciences Products 20-HETE was syntheclzed a$ described earher "
Results
Vascular Reactivity
We examined the effects of 20-HETE under basal and precontracted condmons Under 2 g of basal tone, neither the ethanol vehicle nor 20-HETE had an effect on coronary smooth muscle tone (Fig 1A and 1B) When the vessels were Pratt et al To determme whether the mdomethacm-sensitive portion of the 20-HETE concentration-response curve for relaxation could be caused by the stimulated release of prostacychn, we measured the release of its stable metabohte, 6-keto PGF,,, from coronary artery rings stimulated with 20-HETE The basal release was 908 t 138 pg/mL It was increased m a concentration-related manner by 20-HETE 20-HETE (1 X lOAh mol/L) produced a significant increase above basal (Fig 5) 
Discussion
It has been well documented that neutrophlls infiltrate areas of damaged myocardmm durmg lschemla-reperfislon injury 'Z Once activated, neutrophlls release free radicals, proteases, and metabohtes of arachldomc acid ' We have previously demonstrated that canine neutrophlls produce 20-HETE ' Because 20-HETE has been reported to act as both a vasoconstnctOr'"-2' and a vasodllator," we wondered what the effects of 20-HETE were on coronary vascular tone Therefore, we examined the effects of 20-HETE on bovine coronary arteries Previous studies demonstrated that 20-HETE may induce vasodllator and vasoconstrlctor effects within the same preparation ") The vasodllator effects were partially blocked by mdomethacm, indicating a role for cyclooxygenase metabohtes m mediating a portlon of the 20-HETE-induced vasodllatlon Indomethacm, a cyclooxygenase mhlbltor, attenuated 20-HETE-mduced coronary vasodllatlon, suggesting that at least a portion of the 20-HETE-induced vasodllatlon was mediated by a cyclooxygenase metabohte Because 20-HETE 1s produced and released by neutrophlls," and because 20-HETE relaxations are attenuated by the cyclooxygenase mhlbltor, mdomethacm, our first belief was that 20-HETE, denved from neutrophlls, was metabolized to a vasoactlve compound by cyclooxygenase m endothehal cells, smooth muscle cells, or both However, when vessels were incubated with [3H] 20-HETE, no polar metabohtes were detected Because 20-HETE 1s not metabohzed itself, it 1s possible that 20-HETE stimulates the release of arachldomc acid m endothehal cells, smooth muscle cells, or both and that the free arachldomc acid 1s metabolized by cyclooxygenase to a vasoactive elcosanold such as prostacychn Our results from mcubating bovine coronary artenes with 20-HETE indicate that bovine coronary artenes produce prostacyclm m response to increasing concentrations of 20-HETE It 1s unclear whether there 1s a 20-HETE receptor located on smooth muscle cells, endothehal cells, or both and whether, once it 1s activated, this receptor increases phosphohpase activity, and subsequently the release of free arachldomc acid, or displaces arachldomc acid from membrane lipids Although a 20-HETE receptor has yet to be characterized, precedent does exist for arachldomc acid metabohte receptors The prostacychn analog, Clloprost, was used to characterize a prostacyclm receptor m bovine coronary artery '" These mechamsms could act mdlvldually or m conJunction to mediate the vasodllatory effects of 20-HETE Regardless of the mechanism involved m mediating 20-HETE-induced relaxations, we know that 20-HETE causes U46619-precontracted bovine coronary arteries to relax and that bovine coronary arteries release prostacyclm when exposed to 20-HETE Furthermore, the change m prostacychn concentration Induced by lo-' mol/L 20-HETE reflects a 1 to 3 nmol/L concentration of prostacychn m the buffer This concentration of prostacychn has previously been demonstrated to produce approximately 30% relaxation of precontracted bovine coronary artenes I2 This 1s the same amount of Pratt et al 20-HETE-induced, mdomethacm-sensitive relaxation observed m the present studies Neutrophlls are known to infiltrate damaged myocardlal tissue during lschemla-reperfuslon inJury Neutrophll-induced 1nJm-y that occurs during reperfuslon of a formerly lschetmc myocardlal region apparently results from neutrophll locahzatlon and adherence to tissue damaged by the period of lschemla *') Mlcrovascular plugging, referred to as the "noreflow" phenomenon, may contribute to myocardlal injury that occurs during reperfuslon In fact, neutrophll depletion has been shown to reduce infarct size m these models 3 However, neutrophlls, once activated, release many substances, and it 1s not clear that the damage that occurs during lschemla-reperfuslon injury 1s mediated by arachldomc acid metabohtes Because prostacyclm release 1s often associated with a reduction m coronary thrombosis,'4 It 19 possible that 20-HETE acts to counter the effects of neutrophllor platelet-induced coronary obstruction by releasing prostacyclm It 1s also possible that 20-HETE directly alters neutrophll accumulation Evidence for this comes from a previous study m which we demonstrated that 20-HETE mhlblts A23187-induced aggregation of neutrophlls '
In summary, our results indicate that 20-HETE 1s a potent vasodllator of bovine coronary arteries, a portlon of this vasodllatlon 1s attenuated by the cyclooxygenase inhibitor, mdomethacm Furthermore, 20-HETE 1s not metabolized by bovine coronary arteries Instead, the mdomethacm-sensitive relaxations to 20-HETE are mediated by the release of the vasodllatory prostanold, prostacychn
